Clinical Trial Update: Alpha-blocker Plus Diuretic Combination Therapy as Second-line Treatment for Nocturia in Men [NA]

View source ↗

Summary

This entry reports the completion of a clinical trial evaluating alpha-blocker plus diuretic combination therapy as a second-line treatment for nocturia in men.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia

Snippet

Sponsor: Seoul National University Hospital | Conditions: Nocturia | NA | Status: COMPLETED